NorthWest Biotherapeutics Inc (NWBO)

[Arby2000]

#1 has been seen as necessary to protect against attacks by AF, MRC, other parties allied against NWBO, etc.

However, if #2 happens it would not only render that moot, but also provide much needed acceptance and any protection and promotion that may still be needed. If, as speculated on this board, the likely partner at the dance is MRK, then they have been involved in some shape or another for some time - Duffy's sojourn at NWBO, Keytruda and DCVAX being used at the UCLA trial. So, presumably,some level of due diligence would have already been conducted.

In addition to the time needed for due diligence and deal negotiation, NWBO and MRK may be in discussions with FDA for rGBM (as Flipper was opining) or getting some other ducks lined up. Such discussion would certainly affect the deal parameters, especially the $$. For example, if FDA indicates a favorable tilt for rGBM pursuant to certain conditions being met, it increases the value of NWBO. These discussions could add to the uncertainty in the length of the delay.

All told, IMO, looks like #2 is a strong candidate for the delay.